Match the following clinical and laboratory findings of female genital tract infections to… — USMLE Step 2 CK

Match the following clinical and laboratory findings of female genital tract infections to their most appropriate first-line pharmacotherapy and partner management strategy.

Thin, homogenous, grayish-white vaginal discharge; pH $5.5$ ; wet mount shows stippled epithelial cells with obscured borders.Oral metronidazole $500$ mg twice daily for $7$ days; partner treatment not indicated
Profuse, yellow-green, frothy vaginal discharge; punctate cervical hemorrhages; wet mount shows motile, flagellated protozoa.Oral metronidazole $500$ mg twice daily for $7$ days; partner treatment indicated
Intense vulvar pruritus; thick, white, curdy vaginal discharge; vaginal pH $4.2$ ; KOH prep reveals budding yeast and pseudohyphae.Oral fluconazole $150$ mg single dose; partner treatment not indicated
Mucopurulent cervical discharge; easily induced cervical bleeding (friability); positive nucleic acid amplification test (NAAT) for an obligate intracellular bacterium.Oral doxycycline $100$ mg twice daily for $7$ days; partner treatment indicated

Answer

Bacterial vaginosis is treated with a 7-day course of metronidazole without partner treatment. Trichomoniasis requires a 7-day course of metronidazole with partner treatment. Vulvovaginal candidiasis is treated with a single dose of fluconazole without partner treatment. Chlamydia requires a 7-day course of doxycycline with partner treatment.

Each clinical scenario presents pathognomonic features of a specific gynecologic infection, which dictates both the choice of pharmacotherapy and the need for partner management. Bacterial vaginosis (clue cells, high pH) and trichomoniasis (motile protozoa) both utilize oral metronidazole, but only trichomoniasis requires partner treatment. Vulvovaginal candidiasis (normal pH, pseudohyphae) is treated with fluconazole without partner treatment. Chlamydia (mucopurulent cervicitis, positive NAAT) is treated with doxycycline and requires partner treatment.

Step-by-Step Solution

Analyze the clinical presentation and diagnostic findings for each patient to identify the etiologic pathogen.

The pathogens are identified as Gardnerella vaginalis (bacterial vaginosis), Trichomonas vaginalis, Candida albicans, and Chlamydia trachomatis, respectively.

Accurate diagnosis based on discharge characteristics, pH, and microscopy is the prerequisite for selecting the correct antimicrobial therapy.

Select the guideline-concordant antimicrobial agent and regimen for each infection.

BV and Trichomoniasis (in women) require 7 days of oral metronidazole. Candidiasis requires a single dose of fluconazole. Chlamydia requires 7 days of doxycycline.

Following current CDC STI guidelines ensures optimal eradication and minimizes treatment failure.

Determine if concurrent treatment of sexual partners is necessary.

Partner treatment is indicated for STIs (Trichomoniasis and Chlamydia) but not for dysbiosis or opportunistic fungal overgrowth (BV and Candidiasis).

Treating partners for STIs prevents reinfection and halts community transmission.

Key Concept

Diagnosis and management of common gynecologic infections, including indications for concurrent partner treatment.

Estimated Time:1m 30s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic